Pharmacotherapy of Child and Adolescent Psychiatric Disorders

David Rosenberg 지음

Wiley-Blackwell 2011년 11월 22일 출간

작품소개

책소개

This book fulfils an urgent need for an updated text on pediatric psychopharmacology. It takes a unique approach in discussing recent findings within the context of current issues, including economic and political ones. The book covers the emerging question of treating children who do not yet meet diagnostic criteria for psychosis, e.g, schizophrenia or bipolar disorder, but who are deemed to be at high risk. This is an active area of debate: such children are being treated in certain centers, while others reject this completely. The book addresses the antidepressant controversy, the placebo response and unique strategies for delineating this, and ways to optimize the differential between active medication and placebo. It reviews the impact of recent American Heart Association guidelines for monitoring children on stimulants and other psychotropics. It adheres closely to DSM-IV diagnostic criteria throughout. The book describes the use of newly approved drugs such as Lexapro for treating adolescent depression and the novel compound Intuniv. It covers the TADS and CAMS studies, which evaluated the use of SSRIs alone and in combination with cognitive behavioral therapy for adolescent depression. Other topics include treatment of bipolar disorders, the increasing popularity of generic equivalents, combination pharmacotherapy and the potential dangers of psychotropic medications.Third edition of the first ever book published on pediatric psychopharmacology from renowned editors.Incorporates current developments with regard to SSRIs, their indications and their safety issues, including possible associated suicidal behavior.Addresses concerns about cardiovascular side effects of the new stimulant medications available, and compares to other FDA-approved medications for ADHD.Features many tables, figures and pictorials, making it highly accessible and reader friendly.

목차

List of Contributors, xvForeword, xixChapter 1 Historical Perspectives on Child and Adolescent Psychopharmacology, 1Samuel GershonReferences, 4Chapter 2 Pharmacoepidemiology of Psychotropic Medications in Youth, 7Daniel J. Safer Julie Magno ZitoIntroduction, 7Prevalence and trends for medications prescribed for ADHD, 8Nonstimulant medications for ADHD, 11Antidepressant medication, 11Antipsychotic medication, 13Alpha-agonists, 14Anticonvulsant "mood stabilizers", 15Concomitant psychotropic medication, 15Preschool psychotropic medication use, 17International patterns of psychotropic medication for youth, 17Conclusion, 18References, 18Chapter 3 Off-Label Prescribing of Drugs in Child and Adolescent Psychiatry, 25C. Lindsay DeVaneIntroduction, 25Extent of off-label prescribing, 27Need for psychoactive drug treatments for children and adolescents, 31Legislation supporting pediatric drug development, 33Recommendations to follow when considering off-label prescribing, 35References, 36Chapter 4 The Use of Generic Drugs in Pediatric Psychopharmacology, 39Richard I. Shader Christopher-Paul MilneWhat is a generic drug?, 39Why are we discussing generic drugs?, 39Basic requirements for generic drugs, 40The status of regulations regarding generic drugs and children, 41Abbreviated new drug application (ANDA) requirements, 42Pediatric assessments of adult drugs (history up to current status), 43Best Pharmaceuticals for Children Act, 44Pediatric Research Equity Act, 45Intersection of requirements for generics and pediatric assessment, 46Future directions, 48Concluding thoughts, 49References, 49Chapter 5 Psychoactive Drug Use in Children: Basic Concepts in Clinical Pharmacology, 51David J. EdwardsIntroduction, 51Basic concepts in pharmacokinetics, 52Dosing considera

출판사 서평

&“Pharmacotherapy of Child and Adolescent Psychiatric Disorders is a book to have available on your desk, not just in your library.& It provides ready access to the wealth of practical information and insight for the range of health and mental health professionals.& It is highly recommended for trainees and anyone who is prescribing psychotropic medications to the pediatric population and young adults.”& (Journal of Clinical Psychiatry, 7 July 2012)&&&

인물정보

저자(글) David Rosenberg

저자 :

저자 :

저자 :

저자 :

저자 :
저자 :
저자 :
David Rosenberg MD, Miriam L. Hamburger Endowed Chair of Child Psychiatry and Professor Chief of Child Psychiatry and Psychology at Wayne State University and the Children's Hospital of Michigan, Detroit, MI , USASamuel Gershon MD, Emeritus Professor of Psychiatry, University of Pittsburgh, PA, USA